AnaptysBio Inc (ANAB)
US$ 18.44-1.44%
Price Chart
Key Statistics
Market Cap
$ 634.8M
P/E Ratio
0.00
Revenue (TTM)
$ 91.28M
Volume
1.2M
52W High
$ 41.31
52W Low
$ 12.21
Dividend Yield
0.00%
Beta
-0.09
Technicals
50-Day MA
18.0382
200-Day MA
24.6393
52 Week High
41.3083
52 Week Low
12.21
About ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
Employees
136
Headquarters
San Diego, CA
CEO
Mr. Daniel R. Faga
Latest News
XTX Topco Ltd Buys 19,727 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg